![](https://ml.globenewswire.com/media/3ef08b92-2ba6-4f96-a40d-568557c794a9/small/logo-png.png)
Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”
CAMBRIDGE, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Vyome Therapeutics, a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, announced today that it has signed a …